Lexology January 17, 2025
McDermott Will & Emery

On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations. This proposed rule would establish three special registrations, creating pathways for telehealth practitioners to prescribe, and online platforms to dispense, certain controlled substances via telemedicine after flexibilities expire on December 31, 2025. However, it is unclear whether the incoming Trump administration will move forward with the proposed approach for special registration.

In Depth

WHY IT MATTERS

  • Current federal telehealth-focused controlled substance prescribing flexibilities, initially invoked in response to the COVID-19 public health emergency (PHE), will expire December 31, 2025.
  • Absent the flexibilities, current law would require telemedicine providers to perform an in-person medical evaluation of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Provider, Technology, Telehealth
Are third-party telehealth prescriptions of GLP-1s safe?
Unifying telemedicine efforts can help health systems succeed with virtual care
Telehealth For Menopause: Shifting Care Norms And Expanding Access
Communicating with your doctor online could cost you
Iris Telehealth Acquires innovaTel to Expand Telepsychiatry Services

Share This Article